In honor of Glioblastoma Awareness Day on July 19, 2023, it is crucial to raise awareness about glioblastoma, an aggressive form of brain tumor that affects thousands of individuals worldwide. This article aims to provide an in-depth understanding of glioblastoma, including its definition, diagnosis, treatment options, challenges, research advancements, and supportive care for patients. By sharing this information, we hope to foster knowledge, empathy, and support for those affected by this devastating disease.
Glioblastoma, also known as glioblastoma multiforme (GBM), is the most common and aggressive type of malignant brain tumor in adults. It originates from the glial cells, specifically astrocytes or oligodendrocytes, and is characterized by its infiltrative growth pattern, rapid progression, and high recurrence rate. Treating Glioblastoma has been described as weeding a garden where pesky weeds continue to pop up.
Glioblastoma is relatively rare, accounting for approximately 15% of all primary brain tumors. It occurs more frequently in adults aged 45 and older, with a slightly higher incidence in males. While the exact causes of glioblastoma remain unclear, certain risk factors have been identified, including:
Other possible risk factors for glioblastoma include:
It is important to note that having any of these risk factors does not mean that you will develop glioblastoma. Most people with these risk factors will never develop the disease. However, if you have any of these risk factors, it is important to talk to your doctor about your risk and how to reduce it.
The symptoms of glioblastoma can vary depending on the location and size of the tumor. Common signs and symptoms include:
Prompt and accurate diagnosis of glioblastoma is crucial for determining the appropriate treatment approach. Several diagnostic procedures and staging systems are utilized to evaluate the extent and characteristics of the tumor.
Imaging tests, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans, are used to visualize the brain and identify any abnormalities. These tests provide detailed images that help in locating the tumor and assessing its size and proximity to critical structures.
A biopsy is often performed to obtain a tissue sample for further analysis. The tissue is examined by a pathologist who identifies the specific type of brain tumor, determines its grade, and assesses genetic markers that may guide treatment decisions.
Glioblastoma is commonly staged using the World Health Organization (WHO) classification system, which considers the tumor's size, location, and spread within the brain. The grading system, known as the WHO grading system, helps determine the tumor's aggressiveness based on cellular characteristics and genetic abnormalities.
The treatment approach for glioblastoma involves a multimodal strategy that combines surgery, radiation therapy, and chemotherapy. Additional therapies, such as targeted therapy, immunotherapy, and participation in clinical trials, may also be considered depending on the individual's specific case.
Surgery aims to remove as much of the tumor as possible without causing significant damage to the surrounding healthy brain tissue. It helps alleviate symptoms, establish a diagnosis, and create a conducive environment for other treatment modalities.
Radiation therapy uses high-energy beams to destroy cancer cells and shrink the tumor. It is often administered after surgery to target any remaining tumor cells and prevent recurrence. Advanced techniques, such as intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery, allow for precise delivery of radiation while minimizing damage to healthy tissues.
Chemotherapy drugs are used to kill cancer cells or slow down their growth. In glioblastoma, the most commonly used chemotherapy drug is temozolomide. It is often given in combination with radiation therapy and continued afterward as maintenance treatment.
Targeted therapy involves using drugs that specifically target certain molecular abnormalities present in glioblastoma cells. For example, bevacizumab targets the tumor's blood vessels, inhibiting their growth and preventing the tumor from receiving necessary nutrients.
Immunotherapy harnesses the body's immune system to recognize and attack cancer cells. Therapies such as checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, and tumor vaccines are being studied in clinical trials to evaluate their efficacy in glioblastoma treatment.
Participation in clinical trials provides patients with access to novel treatment approaches and experimental therapies that may offer promising outcomes. Clinical trials help advance scientific knowledge and improve treatment options for glioblastoma.
Despite advancements in treatment, glioblastoma poses significant challenges due to its infiltrative nature and high recurrence rate. The tumor cells can invade surrounding brain tissue, making complete surgical removal difficult. Additionally, glioblastoma cells are often resistant to conventional therapies.
Prognostic factors that influence survival include age, overall health, extent of surgical resection, response to treatment, and molecular characteristics of the tumor. Despite aggressive treatment, the median survival for glioblastoma patients is generally around 15 to 18 months.
Continuous research efforts are focused on understanding the underlying biology of glioblastoma and developing innovative treatment approaches. Genomic studies have revealed various genetic mutations and alterations that may serve as potential targets for personalized therapies. Precision medicine approaches, such as molecular profiling and genomic sequencing, allow for tailored treatment plans based on individual tumor characteristics.
Novel treatment strategies, including gene therapies, immunotherapies, and combination therapies, are being explored to overcome the challenges posed by glioblastoma. Clinical trials investigating innovative drugs and treatment modalities provide hope for improved outcomes in the future.
In addition to medical treatment, maintaining a healthy lifestyle and receiving supportive care can contribute to the overall well-being of glioblastoma patients. Proper nutrition and regular exercise help optimize physical and mental health. Emotional support, counseling, and support groups provide patients and their families with guidance and a platform to share their experiences. Rehabilitation programs aid in managing symptoms and improving functional abilities.
On Glioblastoma Awareness Day, it is essential to raise awareness and understanding about this aggressive brain tumor. Glioblastoma presents numerous challenges, but through continued research, advancements in treatment, and comprehensive supportive care, there is hope for improved outcomes and enhanced quality of life for patients. By fostering empathy and support, we can make a difference in the lives of those affected by glioblastoma.
Glioblastoma's exact causes are still unknown, but factors such as age, family history, radiation exposure, and genetic mutations can contribute to its development.
Currently, there is no known cure for glioblastoma. However, ongoing research and advancements in treatment offer hope for improved outcomes and extended survival.
Since the causes of glioblastoma are not well understood, specific preventive measures are challenging. However, maintaining a healthy lifestyle and minimizing exposure to known risk factors, such as radiation, may help reduce the risk to some extent.
The long-term effects of glioblastoma treatment can vary among individuals. They may include cognitive changes, physical impairments, emotional challenges, and the risk of secondary tumors. Rehabilitation programs and supportive care can help manage these effects.
Supporting a loved one with glioblastoma involves providing emotional support, actively listening to their needs, assisting with daily activities, accompanying them to medical appointments, and staying informed about the disease and treatment options. See more information below.
At Sagely Health, we’ve helped many Glioblastoma patients reach innovative therapies in clinical trials. Learn more about how our cancer consultations work.
Additionally, here are some links to organizations that provide support to Glioblastoma patients:
Most patients are handed a treatment plan and told to begin. But what if there are better options—or steps being missed?
This free 5-day email series helps you understand the hidden opportunities that could shape your care. It covers what many patients wish they had known sooner—before key decisions were made.
You’ll get insights on:
Each short email builds on the last, helping you feel more informed and in control—right when decisions matter most.
Join hundreds of patients gaining clarity and confidence—in just 5 short emails.
